CLINICAL_TRIALS
trial_result
· 2010-09-27
Clinical Trial Update: A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma [Phase 3]
Summary
Phase III trial results for Sorafenib in advanced hepatocellular carcinoma have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED | Results posted: 2010-09-27